课题基金 / 基金详情

High Throughput Screening to Discover Small Molecule Modulators of the Orphan GPCR GPR151

High Throughput Screening to Discover Small Molecule Modulators of the Orphan GPCR GPR151
高通量筛选发现孤儿 GPCR GPR151 的小分子调节剂
批准号:
9191286
负责人:
Thomas D Bannister
金额:
$87.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-04-30

项目摘要

项目成果

Thomas D Bannister的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The orphan G protein-coupled receptor GPR151 has a distinctive distribution pattern in mammalian brains, with highly specific enrichment in a small bilateral brain structure known as the habenula complex. This structure sends projections to the dopaminergic striatum and receives inputs from the limbic forebrain, modulating cross-talk between these brain regions. It is therefore ideally located, both anatomically and functionally, to regulate emotional, motivational and cognitive behaviors. Consequently, it is believed that the habenula plays a critically important role in the pathophysiology of neuropsychiatric disorders such as schizophrenia, depression and drug dependence. The restricted and unique brain expression pattern of GPR151 suggests a role for this receptor in regulating the habenula complex and thus affecting such disorders. In this proposal we will implement and miniaturize a HTS-compatible cell-based functional assay to facilitate the identification of potent GPR151-selective small molecule molecular probes. These molecules will then be optimized and used to interrogate GPR151's role in regulating the habenula complex and the impact of GPR151 modulation upon both normal physiological processes and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core C: Medicinal Chemistry and DMPK
  • 批准号:
    10522807
  • 项目类别:
  • 资助金额:
    $1314.19万
  • 财政年份:
    2022
  • 负责人:
    Thomas D Bannister
  • 依托单位:
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
海外基金